[en] A symposium on kidney stones and mineral metabolism held on December 2017 in Brussels, Belgium was the first international multidisciplinary conference of the International Collaborative Network on Kidney Stones and Mineral Metabolism. This meeting addressed epidemiology, underlying pathophysiological mechanisms, genetics, pathological, as well as clinical and research topics. The participants included clinicians and recognized experts in the field from Europe and the United States interacted closely during the symposium which promoted a chance to explore new frontiers in the field of kidney stone disease. This manuscript summarizes some of the major highlights of the meeting.
Disciplines :
Urology & nephrology
Author, co-author :
Pozdzik, Agnieszka
Maalouf, Naim
Letavernier, Emmanuel
Brocheriou, Isabelle
CASTIGLIONE, Vincent ; Centre Hospitalier Universitaire de Liège - CHU > Unilab > Laboratoire allergologie - lithiases
Language :
English
Title :
Meeting report of the "Symposium on kidney stones and mineral metabolism: calcium kidney stones in 2017"
Sakhaee, K., Maalouf, N.M., Sinnott, B., Clinical review. Kidney stones 2012: pathogenesis, diagnosis, and management (2012) J Clin Endocrinol Metab, 97 (6), pp. 1847-1860
Romero, V., Akpinar, H., Assimos, D.G., Kidney stones: a global picture of prevalence, incidence, and associated risk factors (2010) Rev Urol, 12 (2-3), pp. e86-e96
Shuster, J., Scheaffer, R.L., Economic impact of kidney stones in white male adults (1984) Urology, 24 (4), pp. 327-331
Cone, E.B., Hammill, B.G., Routh, J.C., Lipkin, M.E., Preminger, G.M., Schmader, K.E., Disproportionate use of inpatient care by older adults with kidney stones (2018) Urology, 120, pp. 103-108
Scales, C.D., Jr., Smith, A.C., Hanley, J.M., Saigal, C.S., Prevalence of kidney stones in the United States (2012) Eur Urol, 62 (1), pp. 160-165
Zeng, G., Mai, Z., Xia, S., Wang, Z., Zhang, K., Wang, L., Prevalence of kidney stones in China: an ultrasonography based cross-sectional study (2017) BJU Int, 120 (1), pp. 109-116
Ramello, A., Vitale, C., Marangella, M., Epidemiology of nephrolithiasis (2000) J Nephrol, 13, pp. S45-S50
Xu, L.H.R., Adams-Huet, B., Poindexter, J.R., Maalouf, N.M., Moe, O.W., Sakhaee, K., Temporal changes in kidney stone composition and in risk factors predisposing to stone formation (2017) J Urol, 197 (6), pp. 1465-1471
Shavit, L., Ferraro, P.M., Johri, N., Robertson, W., Walsh, S.B., Moochhala, S., Effect of being overweight on urinary metabolic risk factors for kidney stone formation (2015) Nephrol Dial Transpl, 30 (4), pp. 607-613
Daudon, M., [Epidemiology of nephrolithiasis in France] (2005) Ann Urol (Paris), 39 (6), pp. 209-231
Mandel, N., Mandel, I., Fryjoff, K., Rejniak, T., Mandel, G., Conversion of calcium oxalate to calcium phosphate with recurrent stone episodes (2003) J Urol, 169 (6), pp. 2026-2029
Daudon, M., Donsimoni, R., Hennequin, C., Fellahi, S., Le Moel, G., Paris, M., Sex- and age-related composition of 10 617 calculi analyzed by infrared spectroscopy (1995) Urol Res, 23 (5), pp. 319-326
Rule, A.D., Bergstralh, E.J., Melton, L.J., 3rd, Li, X., Weaver, A.L., Lieske, J.C., Kidney stones and the risk for chronic kidney disease (2009) Clin J Am Soc Nephrol, 4 (4), pp. 804-811
Maeda, S., Naganuma, T., Takemoto, Y., Shoji, T., Okamura, M., Nakatani, T., Chronic kidney disease in urolithiasis patients following successful extracorporeal shockwave lithotripsy (2012) Mol Med Rep, 5 (1), pp. 3-6
Shang, W., Li, L., Ren, Y., Ge, Q., Ku, M., Ge, S., History of kidney stones and risk of chronic kidney disease: a meta-analysis (2017) PeerJ, 5
Rule, A.D., Krambeck, A.E., Lieske, J.C., Chronic kidney disease in kidney stone formers (2011) Clin J Am Soc Nephrol, 6 (8), pp. 2069-2075
Goldfarb, D.S., Fischer, M.E., Keich, Y., Goldberg, J., A twin study of genetic and dietary influences on nephrolithiasis: a report from the Vietnam Era Twin (VET) Registry (2005) Kidney Int, 67 (3), pp. 1053-1061
Gambaro, G., Vezzoli, G., Casari, G., Rampoldi, L., D’Angelo, A., Borghi, L., Genetics of hypercalciuria and calcium nephrolithiasis: from the rare monogenic to the common polygenic forms (2004) Am J Kidney Dis, 44 (6), pp. 963-986
Edvardsson, V.O., Palsson, R., Indridason, O.S., Thorvaldsson, S., Stefansson, K., Familiality of kidney stone disease in Iceland (2009) Scand J Urol Nephrol, 43 (5), pp. 420-424
Guerra, A., Folesani, G., Nouvenne, A., Ticinesi, A., Allegri, F., Pinelli, S., Family history influences clinical course of idiopathic calcium nephrolithiasis: case-control study of a large cohort of Italian patients (2016) J Nephrol, 29 (5), pp. 645-651
Toka, H.R., Genovese, G., Mount, D.B., Pollak, M.R., Curhan, G.C., Frequency of rare allelic variation in candidate genes among individuals with low and high urinary calcium excretion (2013) PLoS One, 8 (8)
Thorleifsson, G., Holm, H., Edvardsson, V., Walters, G.B., Styrkarsdottir, U., Gudbjartsson, D.F., Sequence variants in the CLDN14 gene associate with kidney stones and bone mineral density (2009) Nat Genet, 41 (8), pp. 926-930
Yasui, T., Okada, A., Urabe, Y., Usami, M., Mizuno, K., Kubota, Y., A replication study for three nephrolithiasis loci at 5q35.3, 7p14.3 and 13q14.1 in the Japanese population (2013) J Hum Genet, 58 (9), pp. 588-593
Oliveira, B., Kleta, R., Bockenhauer, D., Walsh, S.B., Genetic, pathophysiological, and clinical aspects of nephrocalcinosis (2016) Am J Physiol Renal Physiol, 311 (6), pp. F1243-F1252
Shavit, L., Jaeger, P., Unwin, R.J., What is nephrocalcinosis? (2015) Kidney Int, 88 (1), pp. 35-43
Michalus, I., Rusinska, A., Rare, genetically conditioned forms of rickets: Differential diagnosis and advances in diagnostics and treatment (2018) Clin Genet, 94 (1), pp. 103-114
Sayer, J.A., Carr, G., Simmons, N.L., Nephrocalcinosis: molecular insights into calcium precipitation within the kidney (2004) Clin Sci (Lond), 106 (6), pp. 549-561
Taguchi, K., Yasui, T., Milliner, D.S., Hoppe, B., Chi, T., Genetic risk factors for idiopathic urolithiasis: a systematic review of the literature and causal network analysis (2017) Eur Urol Focus, 3 (1), pp. 72-81
Halbritter, J., Baum, M., Hynes, A.M., Rice, S.J., Thwaites, D.T., Gucev, Z.S., Fourteen monogenic genes account for 15% of nephrolithiasis/nephrocalcinosis (2015) J Am Soc Nephrol, 26 (3), pp. 543-551
Braun, D.A., Lawson, J.A., Gee, H.Y., Halbritter, J., Shril, S., Tan, W., Prevalence of monogenic causes in pediatric patients with nephrolithiasis or nephrocalcinosis (2016) Clin J Am Soc Nephrol, 11 (4), pp. 664-672
Daga, A., Majmundar, A.J., Braun, D.A., Gee, H.Y., Lawson, J.A., Shril, S., Whole exome sequencing frequently detects a monogenic cause in early onset nephrolithiasis and nephrocalcinosis (2018) Kidney Int, 93 (1), pp. 204-213
Pelle, A., Cuccurullo, A., Mancini, C., Sebastiano, R., Stallone, G., Negrisolo, S., Updated genetic testing of Italian patients referred with a clinical diagnosis of primary hyperoxaluria (2017) J Nephrol, 30 (2), pp. 219-225
Diefenhardt, P., Nosko, A., Kluger, M.A., Richter, J.V., Wegscheid, C., Kobayashi, Y., IL-10 receptor signaling empowers regulatory T cells to control Th17 responses and protect from GN (2018) J Am Soc Nephrol, 29 (7), pp. 1825-1837
Cloutier, J., Villa, L., Traxer, O., Daudon, M., Kidney stone analysis: “Give me your stone, I will tell you who you are! (2015) World J Urol, 33 (2), pp. 157-169
Siener, R., Buchholz, N., Daudon, M., Hess, B., Knoll, T., Osther, P.J., Quality assessment of urinary stone analysis: results of a multicenter study of laboratories in Europe (2016) PLoS One, 11 (6)
Daudon, M., Dessombz, A., Frochot, V., Letavernier, E., Haymann, J.P., Jungers, P., Bazin, D., Comprehensive morpho-constitutional analysis of urinary stones improves etiological diagnosis and therapeutic strategy of nephrlithiasis (2016) C R Chim, 19, pp. 1470-1491
Reveillaud, R.J., Daudon, M., Protat, M.F., Ayrole, G., Analysis of urinary calculi in adults. Attempt of correlations between morphology and composition (1980) Eur Urol, 6 (3), pp. 161-165
Daudon, M., Estepa, L., Lacour, B., Jungers, P., Unusual morphology of calcium oxalate calculi in primary hyperoxaluria (1998) J Nephrol, 11, pp. 51-55
Sakhaee, K., Maalouf, N.M., Metabolic syndrome and uric acid nephrolithiasis (2008) Semin Nephrol, 28 (2), pp. 174-180
Maalouf, N.M., Cameron, M.A., Moe, O.W., Adams-Huet, B., Sakhaee, K., Low urine pH: a novel feature of the metabolic syndrome (2007) Clin J Am Soc Nephrol, 2 (5), pp. 883-888
Goldfarb, D.S., Hirsch, J., Hypothesis, Urbanization and exposure to urban heat islands contribute to increasing prevalence of kidney stones (2015) Med Hypotheses, 85 (6), pp. 953-957
Ferraro, P.M., Curhan, G.C., D’Addessi, A., Gambaro, G., Risk of recurrence of idiopathic calcium kidney stones: analysis of data from the literature (2017) J Nephrol, 30 (2), pp. 227-233
Vervaet, B.A., Verhulst, A., D’Haese, P.C., De Broe, M.E., Nephrocalcinosis: new insights into mechanisms and consequences (2009) Nephrol Dial Transpl, 24 (7), pp. 2030-2035
Vervaet, B.A., D’Haese, P.C., De Broe, M.E., Verhulst, A., Crystalluric and tubular epithelial parameters during the onset of intratubular nephrocalcinosis: illustration of the ‘fixed particle’ theory in vivo (2009) Nephrol Dial Transpl, 24 (12), pp. 3659-3668
Vervaet, B.A., Verhulst, A., De Broe, M.E., D’Haese, P.C., The tubular epithelium in the initiation and course of intratubular nephrocalcinosis (2010) Urol Res, 38 (4), pp. 249-256
Verhulst, A., Asselman, M., De Naeyer, S., Vervaet, B.A., Mengel, M., Gwinner, W., Preconditioning of the distal tubular epithelium of the human kidney precedes nephrocalcinosis (2005) Kidney Int, 68 (4), pp. 1643-1647
Letavernier, E., Vandermeersch, S., Traxer, O., Tligui, M., Baud, L., Ronco, P., Demographics and characterization of 10,282 Randall plaque-related kidney stones: a new epidemic? (2015) Medicine (Baltimore), 94 (10)
Verrier, C., Bazin, D., Huguet, L., Stephan, O., Gloter, A., Verpont, M.C., Topography, composition and structure of incipient randall plaque at the nanoscale level (2016) J Urol, 196 (5), pp. 1566-1574
Letavernier, E., Daudon, M., Vitamin D, Hypercalciuria and kidney stones (2018) Nutrients, 10 (3), p. 366
Letavernier, E., Daudon, M., Stones, Tolvaptan might prevent kidney stone formation (2016) Nat Rev Urol, 13 (3), pp. 130-131
Letavernier, E., Kauffenstein, G., Huguet, L., Navasiolava, N., Bouderlique, E., Tang, E., ABCC6 deficiency promotes development of randall plaque (2018) J Am Soc Nephrol, 29, p. 23372347
Kumakura, S., Nakaya, I., Sakuma, T., Sato, H., Soma, J., Crystalline cast nephropathy in a patient with IgD lambda myeloma (2016) Clin Exp Nephrol, 20 (3), pp. 491-492
Gupta, V., El Ters, M., Kashani, K., Leung, N., Nasr, S.H., Crystalglobulin-induced nephropathy (2015) J Am Soc Nephrol, 26 (3), pp. 525-529
Chatchen, S., Pongsakul, N., Srisomsap, C., Chiangjong, W., Hongeng, S., Svasti, J., Unravelling pathophysiology of crystalline nephropathy in ceftriaxone-associated acute kidney injury: a cellular proteomic approach (2018) Nephron, 139 (1), pp. 70-82
Carbone, L.G., Bendixen, B., Appel, G.B., Sulfadiazine-associated obstructive nephropathy occurring in a patient with the acquired immunodeficiency syndrome (1988) Am J Kidney Dis, 12 (1), pp. 72-75
Sawyer, M.H., Webb, D.E., Balow, J.E., Straus, S.E., Acyclovir-induced renal failure. Clinical course and histology (1988) Am J Med, 84 (6), pp. 1067-1071
Nasr, S.H., Milliner, D.S., Wooldridge, T.D., Sethi, S., Triamterene crystalline nephropathy (2014) Am J Kidney Dis, 63 (1), pp. 148-152
Santoriello, D., Al-Nabulsi, M., Reddy, A., Salamera, J., D’Agati, V.D., Markowitz, G.S., Atazanavir-associated crystalline nephropathy (2017) Am J Kidney Dis, 70 (4), pp. 576-580
Daudon, M., Frochot, V., Bazin, D., Jungers, P., Drug-induced kidney stones and crystalline nephropathy: pathophysiology, prevention and treatment (2018) Drugs, 78 (2), pp. 163-201
Cartery, C., Faguer, S., Karras, A., Cointault, O., Buscail, L., Modesto, A., Oxalate nephropathy associated with chronic pancreatitis (2011) Clin J Am Soc Nephrol, 6 (8), pp. 1895-1902
Chuang, Y.W., Wen, M.C., Wu, M.J., Shu, K.H., Cheng, C.H., Yu, T.M., Follow-up and treatment of renal transplantation with nephropathic cystinosis in central Taiwan (2012) Transpl Proc, 44 (1), p. 8082
Ceballos-Picot, I., Perignon, J.L., Hamet, M., Daudon, M., Kamoun, P., 2,8-Dihydroxyadenine urolithiasis, an underdiagnosed disease (1992) Lancet, 339 (8800), pp. 1050-1051
Bollee, G., Cochat, P., Daudon, M., Recurrence of crystalline nephropathy after kidney transplantation in APRT deficiency and primary hyperoxaluria (2015) Can J Kidney Health Dis, 2, p. 31
Fogazzi, G.B., Crystalluria: a neglected aspect of urinary sediment analysis (1996) Nephrol Dial Transpl, 11 (2), pp. 379-387
Daudon, M., Frochot, V., Crystalluria (2015) Clin Chem Lab Med, 53, pp. s1479-s1487
Scales, C.D., Jr., Tasian, G.E., Schwaderer, A.L., Goldfarb, D.S., Star, R.A., Kirkali, Z., Urinary stone disease: advancing knowledge, patient care, and population health (2016) Clin J Am Soc Nephrol, 11 (7), pp. 1305-1312
Tasian, G.E., Ross, M.E., Song, L., Sas, D.J., Keren, R., Denburg, M.R., Annual incidence of nephrolithiasis among children and adults in South Carolina from 1997 to 2012 (2016) Clin J Am Soc Nephrol, 11 (3), pp. 488-496
Jungers, P., Joly, D., Barbey, F., Choukroun, G., Daudon, M., ESKD caused by nephrolithiasis: prevalence, mechanisms, and prevention (2004) Am J Kidney Dis, 44 (5), pp. 799-805
Alexander, R.T., Hemmelgarn, B.R., Wiebe, N., Bello, A., Morgan, C., Samuel, S., Kidney stones and kidney function loss: a cohort study (2012) BMJ, 345
Denburg, M.R., Jemielita, T.O., Tasian, G.E., Haynes, K., Mucksavage, P., Shults, J., Assessing the risk of incident hypertension and chronic kidney disease after exposure to shock wave lithotripsy and ureteroscopy (2016) Kidney Int, 89 (1), pp. 185-192
El-Zoghby, Z.M., Lieske, J.C., Foley, R.N., Bergstralh, E.J., Li, X., Melton, L.J., 3rd, Urolithiasis and the risk of ESKD (2012) Clin J Am Soc Nephrol, 7 (9), pp. 1409-1415
Gambaro, G., Croppi, E., Bushinsky, D., Jaeger, P., Cupisti, A., Ticinesi, A., The risk of chronic kidney disease associated with urolithiasis and its urological treatments: a review (2017) J Urol, 198 (2), pp. 268-273
Spatola, L., Angelini, C., Badalamenti, S., Maringhini, S., Gambaro, G., Kidney stones diseases and glycaemic statuses: focus on the latest clinical evidences (2017) Urolithiasis, 45 (5), pp. 457-460
Worcester, E.M., Parks, J.H., Evan, A.P., Coe, F.L., Renal function in patients with nephrolithiasis (2006) J Urol, 176 (2), pp. 600-603. , (discussion 3
Connors, B.A., Evan, A.P., Willis, L.R., Blomgren, P.M., Lingeman, J.E., Fineberg, N.S., The effect of discharge voltage on renal injury and impairment caused by lithotripsy in the pig (2000) J Am Soc Nephrol, 11 (2), pp. 310-318
Petrucci, I., Clementi, A., Sessa, C., Torrisi, I., Meola, M., Ultrasound and color Doppler applications in chronic kidney disease (2018) J Nephrol, 31 (6), pp. 863-879
Zerwekh, J.E., Hwang, T.I., Poindexter, J., Hill, K., Wendell, G., Pak, C.Y., Modulation by calcium of the inhibitor activity of naturally occurring urinary inhibitors (1988) Kidney Int, 33 (5), pp. 1005-1008
Ettinger, B., Citron, J.T., Livermore, B., Dolman, L.I., Chlorthalidone reduces calcium oxalate calculous recurrence but magnesium hydroxide does not (1988) J Urol, 139 (4), pp. 679-684
Norman, D.A., Zerwekh, J.E., Pak, C.Y., An apparent 1,25-dihydroxyvitamin D-independent stimulation of intestinal calcium absorption in patients with Paget disease of bone during a short-term diphosphonate therapy (1981) Metabolism, 30 (3), pp. 290-292
Tebben, P.J., Milliner, D.S., Horst, R.L., Harris, P.C., Singh, R.J., Wu, Y., Hypercalcemia, hypercalciuria, and elevated calcitriol concentrations with autosomal dominant transmission due to CYP24A1 mutations: effects of ketoconazole therapy (2012) J Clin Endocrinol Metab, 97 (3), pp. E423-E427
Kaufman, D.W., Kelly, J.P., Curhan, G.C., Anderson, T.E., Dretler, S.P., Preminger, G.M., Oxalobacter formigenes may reduce the risk of calcium oxalate kidney stones (2008) J Am Soc Nephrol, 19 (6), pp. 1197-1203
Ricagno, S., Jonsson, S., Richards, N., Lindqvist, Y., Formyl-CoA transferase encloses the CoA binding site at the interface of an interlocked dimer (2003) EMBO J, 22 (13), pp. 3210-3219
Siener, R., Bangen, U., Sidhu, H., Honow, R., von Unruh, G., Hesse, A., The role of Oxalobacter formigenes colonization in calcium oxalate stone disease (2013) Kidney Int, 83 (6), pp. 1144-1149
Maalouf, N.M., Moe, O.W., Adams-Huet, B., Sakhaee, K., Hypercalciuria associated with high dietary protein intake is not due to acid load (2011) J Clin Endocrinol Metab, 96 (12), pp. 3733-3740
Ticinesi, A., Guerra, A., Allegri, F., Nouvenne, A., Cervellin, G., Maggio, M., Determinants of calcium and oxalate excretion in subjects with calcium nephrolithiasis: the role of metabolic syndrome traits (2018) J Nephrol, 31 (3), pp. 395-403
Adami, S., Marcocci, C., Gatti, D., Epidemiology of primary hyperparathyroidism in Europe (2002) J Bone Miner Res, 17, pp. N18-N23
Bilezikian, J.P., Silverberg, S.J., Clinical practice. Asymptomatic primary hyperparathyroidism (2004) N Engl J Med, 350 (17), pp. 1746-1751
Lal, G., Clark, O.H., Primary hyperparathyroidism: controversies in surgical management (2003) Trends Endocrinol Metab, 14 (9), pp. 417-422
Bilezikian, J.P., Potts, J.T., Jr., Fuleihan Gel, H., Kleerekoper, M., Neer, R., Peacock, M., Summary statement from a workshop on asymptomatic primary hyperparathyroidism: a perspective for the 21st century (2002) J Clin Endocrinol Metab, 87 (12), pp. 5353-5361
Bilezikian, J.P., Potts, J.T., Jr., Asymptomatic primary hyperparathyroidism: new issues and new questions—bridging the past with the future (2002) J Bone Miner Res, 17, pp. N57-N67
Ruda, J.M., Hollenbeak, C.S., Stack, B.C., Jr., Jr. A systematic review of the diagnosis and treatment of primary hyperparathyroidism from 1995 to 2003 (2005) Otolaryngol Head Neck Surg, 132 (3), pp. 359-372
Daudon, M., Lacour, B., Jungers, P., Influence of body size on urinary stone composition in men and women (2006) Urol Res, 34 (3), pp. 193-199
Sakhaee, K., Nephrolithiasis as a systemic disorder (2008) Curr Opin Nephrol Hypertens, 17 (3), pp. 304-309
Sakhaee, K., Epidemiology and clinical pathophysiology of uric acid kidney stones (2014) J Nephrol, 27 (3), pp. 241-245
Maalouf, N.M., Cameron, M.A., Moe, O.W., Sakhaee, K., Metabolic basis for low urine pH in type 2 diabetes (2010) Clin J Am Soc Nephrol, 5 (7), pp. 1277-1281
Daudon, M., Traxer, O., Conort, P., Lacour, B., Jungers, P., Type 2 diabetes increases the risk for uric acid stones (2006) J Am Soc Nephrol, 17 (7), pp. 2026-2033
Fernandez, A., Fuller, A., Al-Bareeq, R., Nott, L., Razvi, H., A comparison of the metabolic profiles of diabetic and non-diabetic uric acid stone formers (2013) Can Urol Assoc J, 7 (3-4), pp. E190-E192
Nikiforova, V.J., Giesbertz, P., Wiemer, J., Bethan, B., Looser, R., Liebenberg, V., Glyoxylate, a new marker metabolite of type 2 diabetes (2014) J Diabetes Res, 2014, p. 685204
Burdin, D.V., Kolobov, A.A., Brocker, C., Soshnev, A.A., Samusik, N., Demyanov, A.V., Diabetes-linked transcription factor HNF4alpha regulates metabolism of endogenous methylarginines and beta-aminoisobutyric acid by controlling expression of alanine-glyoxylate aminotransferase 2 (2016) Sci Rep, 6, p. 35503
Curhan, G.C., Willett, W.C., Speizer, F.E., Spiegelman, D., Stampfer, M.J., Comparison of dietary calcium with supplemental calcium and other nutrients as factors affecting the risk for kidney stones in women (1997) Ann Intern Med, 126 (7), pp. 497-504
Sakhaee, K., Poindexter, J.R., Griffith, C.S., Pak, C.Y., Stone forming risk of calcium citrate supplementation in healthy postmenopausal women (2004) J Urol, 172 (3), pp. 958-961
Karp, H.J., Ketola, M.E., Lamberg-Allardt, C.J., Acute effects of calcium carbonate, calcium citrate and potassium citrate on markers of calcium and bone metabolism in young women (2009) Br J Nutr, 102 (9), pp. 1341-1347
Green, J.H., Booth, C., Bunning, R., Acute effect of high-calcium milk with or without additional magnesium, or calcium phosphate on parathyroid hormone and biochemical markers of bone resorption (2003) Eur J Clin Nutr, 57 (1), pp. 61-68
Ketha, H., Singh, R.J., Grebe, S.K., Bergstralh, E.J., Rule, A.D., Lieske, J.C., Altered calcium and vitamin D homeostasis in first-time calcium kidney stone-formers (2015) PLoS One, 10 (9)
Hu, H., Zhang, J., Lu, Y., Zhang, Z., Qin, B., Gao, H., Association between circulating vitamin D Level and urolithiasis: a systematic review and meta-analysis (2017) Nutrients, 9 (3), p. 301
Bambach, C.P., Robertson, W.G., Peacock, M., Hill, G.L., Effect of intestinal surgery on the risk of urinary stone formation (1981) Gut, 22 (4), pp. 257-263
Kumar, R., Lieske, J.C., Collazo-Clavell, M.L., Sarr, M.G., Olson, E.R., Vrtiska, T.J., Fat malabsorption and increased intestinal oxalate absorption are common after Roux-en-Y gastric bypass surgery (2011) Surgery, 149 (5), pp. 654-661
Lieske, J.C., Mehta, R.A., Milliner, D.S., Rule, A.D., Bergstralh, E.J., Sarr, M.G., Kidney stones are common after bariatric surgery (2015) Kidney Int, 87 (4), pp. 839-845
Canales, B.K., Hatch, M., Kidney stone incidence and metabolic urinary changes after modern bariatric surgery: review of clinical studies, experimental models, and prevention strategies (2014) Surg Obes Relat Dis, 10 (4), pp. 734-742
Pareek, G., Armenakas, N.A., Panagopoulos, G., Bruno, J.J., Fracchia, J.A., Extracorporeal shock wave lithotripsy success based on body mass index and Hounsfield units (2005) Urology, 65 (1), pp. 33-36
Castiglione, V., Jouret, F., Bruyere, O., Dubois, B., Thomas, A., Waltregny, D., [Epidemiology of urolithiasis in Belgium on the basis of a morpho-constitutional classification] (2015) Nephrol Ther, 11 (1), pp. 42-49
Sakhaee, K., Medical measures for secondary prevention of urolithiasis (2017) Eur Urol Focus, 3 (1), pp. 10-12
Sakhaee, K., Harvey, J.A., Padalino, P.K., Whitson, P., Pak, C.Y., The potential role of salt abuse on the risk for kidney stone formation (1993) J Urol, 150 (2), pp. 310-312
Sakhaee, K., Williams, R.H., Oh, M.S., Padalino, P., Adams-Huet, B., Whitson, P., Alkali absorption and citrate excretion in calcium nephrolithiasis (1993) J Bone Miner Res, 8 (7), pp. 789-794
Gambaro, G., Croppi, E., Coe, F., Lingeman, J., Moe, O., Worcester, E., Metabolic diagnosis and medical prevention of calcium nephrolithiasis and its systemic manifestations: a consensus statement (2016) J Nephrol, 29 (6), pp. 715-734
